Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-02-21 to 2024-02-22
Current total value of award: $855
Description: 4563817868!IBANDRONATE 3 MG/3 ML SYRINGE 3ML